ArticleChem & bio engineering2025
Type III Collagen Promotes Pseudopodium-Driven Cell Migration.
Article in Chem & bio engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comparative analysis of collagen from different sources for wound and burn management.Biomaterials translational · 2026Article
- The Duality of Collagens in Metastases of Solid Tumors.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The extracellular matrix (ECM), particularly collagen, is acknowledged for its significant impact on cell migration. However, the detailed mechanisms through which it influences pseudopodium formation and cell motility are not yet fully understood. This study delves into the impact of recombinant human type III collagen (hCOL3) on cell migration, specifically focusing on the dynamics of pseudopodia and their contribution to cell motility. The research evaluates the impact of a fragmented form of hCOL3, engineered for the study, on cell motility and pseudopodium behavior using both single-cell and collective-cell migration assays. The results demonstrate that hCOL3 promotes cell migration velocity, augments the effective diffusion coefficient, and enhances directionality in both single-cell and collective migration contexts. Observations from scanning electron microscopy reveal that treatment with hCOL3 increases both the number and length of filopodia, which are crucial for cell migration and interaction with the ECM. The study suggests that hCOL3 facilitates a more targeted and rapid migration. The presence of an increased number of filopodia on surfaces treated with hCOL3 enhances the cell's ability to detect environmental cues and extent, thereby augmenting its migratory capacity. This discovery could potentially lead to greater efficiency in wound healing processes.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.